Reversible paraparesis due to extramedullary hematopoiesis

Area of Science:

• Neurology
• Hematology
• Oncology

Background:

• Thalassemia is a genetic blood disorder.
• Spastic paraplegia is a neurological condition characterized by muscle stiffness and spasms in the legs.
• Extramedullary hematopoiesis (EMH) is the formation of blood cells outside the bone marrow.

Observation:

• Extramedullary hematopoiesis can present as a mass lesion.
• This mass can compress the spinal cord, leading to neurological deficits such as spastic paraplegia.
• This presentation is particularly relevant in patients with thalassemia, a condition often associated with extramedullary hematopoiesis.

Findings:

• Extramedullary hematopoiesis should be included in the differential diagnosis for spastic paraplegia in thalassemia patients.
• Radiotherapy is the primary treatment modality for symptomatic extramedullary hematopoiesis causing spinal cord compression.
• Patients treated with radiotherapy can expect a regain of motor power.

Implications:

• Early consideration of extramedullary hematopoiesis in the diagnostic workup of spastic paraplegia in thalassemia is crucial.
• Effective treatment with radiotherapy can reverse neurological deficits and improve quality of life.
• This highlights the importance of multidisciplinary management involving hematologists, neurologists, and radiation oncologists.